Skip to main content
. Author manuscript; available in PMC: 2021 Apr 18.
Published in final edited form as: Biol Blood Marrow Transplant. 2018 Feb 9;24(5):1094ā€“1098. doi: 10.1016/j.bbmt.2018.01.019

Figure 2. Cervical cancer screening rates within 24 months after stem cell transplant, by 6-month periods.

Figure 2.

All cervical cancer screening rates between the allogeneic SCT and autologous SCT groups were significantly different (pā‰¤0.05), except at 19ā€“24 months. The screening rate in each 6-month period after SCT was calculated by using the number of persons who had screening during that 6 month interval divided by the total number of persons who had not yet received any screening at the beginning of that interval (in white).